These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 25713305)

  • 1. Activation of PPARδ signaling improves skeletal muscle oxidative metabolism and endurance function in an animal model of ischemic left ventricular dysfunction.
    Zizola C; Kennel PJ; Akashi H; Ji R; Castillero E; George I; Homma S; Schulze PC
    Am J Physiol Heart Circ Physiol; 2015 May; 308(9):H1078-85. PubMed ID: 25713305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulating PPARδ signaling as a potential therapeutic strategy for skeletal muscle disorders in heart failure.
    Myers RB; Yoshioka J
    Am J Physiol Heart Circ Physiol; 2015 May; 308(9):H967-9. PubMed ID: 25770240
    [No Abstract]   [Full Text] [Related]  

  • 3. Empagliflozin restores lowered exercise endurance capacity via the activation of skeletal muscle fatty acid oxidation in a murine model of heart failure.
    Nambu H; Takada S; Fukushima A; Matsumoto J; Kakutani N; Maekawa S; Shirakawa R; Nakano I; Furihata T; Katayama T; Yamanashi K; Obata Y; Saito A; Yokota T; Kinugawa S
    Eur J Pharmacol; 2020 Jan; 866():172810. PubMed ID: 31738936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain-Derived Neurotrophic Factor Improves Impaired Fatty Acid Oxidation Via the Activation of Adenosine Monophosphate-Activated Protein Kinase-ɑ - Proliferator-Activated Receptor-r Coactivator-1ɑ Signaling in Skeletal Muscle of Mice With Heart Failure.
    Matsumoto J; Takada S; Furihata T; Nambu H; Kakutani N; Maekawa S; Mizushima W; Nakano I; Fukushima A; Yokota T; Tanaka S; Handa H; Sabe H; Kinugawa S
    Circ Heart Fail; 2021 Jan; 14(1):e005890. PubMed ID: 33356364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of peroxisome proliferator-activated receptor-{delta} by GW501516 prevents fatty acid-induced nuclear factor-{kappa}B activation and insulin resistance in skeletal muscle cells.
    Coll T; Alvarez-Guardia D; Barroso E; Gómez-Foix AM; Palomer X; Laguna JC; Vázquez-Carrera M
    Endocrinology; 2010 Apr; 151(4):1560-9. PubMed ID: 20185762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin improves exercise performance of mice with coronary artery ligation-induced HFrEF: Nrf2 and antioxidant mechanisms in skeletal muscle.
    Wafi AM; Hong J; Rudebush TL; Yu L; Hackfort B; Wang H; Schultz HD; Zucker IH; Gao L
    J Appl Physiol (1985); 2019 Feb; 126(2):477-486. PubMed ID: 30462567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein acetylation in skeletal muscle mitochondria is involved in impaired fatty acid oxidation and exercise intolerance in heart failure.
    Tsuda M; Fukushima A; Matsumoto J; Takada S; Kakutani N; Nambu H; Yamanashi K; Furihata T; Yokota T; Okita K; Kinugawa S; Anzai T
    J Cachexia Sarcopenia Muscle; 2018 Oct; 9(5):844-859. PubMed ID: 30168279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of AMP kinase and PPARdelta in the regulation of lipid and glucose metabolism in human skeletal muscle.
    Krämer DK; Al-Khalili L; Guigas B; Leng Y; Garcia-Roves PM; Krook A
    J Biol Chem; 2007 Jul; 282(27):19313-20. PubMed ID: 17500064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A metabolomic study of the PPARδ agonist GW501516 for enhancing running endurance in Kunming mice.
    Chen W; Gao R; Xie X; Zheng Z; Li H; Li S; Dong F; Wang L
    Sci Rep; 2015 May; 5():9884. PubMed ID: 25943561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective Effect of Unsaturated Fatty Acids on Palmitic Acid-Induced Toxicity in Skeletal Muscle Cells is not Mediated by PPARδ Activation.
    Tumova J; Malisova L; Andel M; Trnka J
    Lipids; 2015 Oct; 50(10):955-64. PubMed ID: 26255030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome.
    Tanaka T; Yamamoto J; Iwasaki S; Asaba H; Hamura H; Ikeda Y; Watanabe M; Magoori K; Ioka RX; Tachibana K; Watanabe Y; Uchiyama Y; Sumi K; Iguchi H; Ito S; Doi T; Hamakubo T; Naito M; Auwerx J; Yanagisawa M; Kodama T; Sakai J
    Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15924-9. PubMed ID: 14676330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PPARdelta agonist, GW501516, promotes fatty acid oxidation but has no direct effect on glucose utilisation or insulin sensitivity in rat L6 skeletal muscle cells.
    Dimopoulos N; Watson M; Green C; Hundal HS
    FEBS Lett; 2007 Oct; 581(24):4743-8. PubMed ID: 17869249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol improves exercise performance and skeletal muscle oxidative capacity in heart failure.
    Sung MM; Byrne NJ; Robertson IM; Kim TT; Samokhvalov V; Levasseur J; Soltys CL; Fung D; Tyreman N; Denou E; Jones KE; Seubert JM; Schertzer JD; Dyck JR
    Am J Physiol Heart Circ Physiol; 2017 Apr; 312(4):H842-H853. PubMed ID: 28159807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of xanthine oxidase in the acute phase of myocardial infarction prevents skeletal muscle abnormalities and exercise intolerance.
    Nambu H; Takada S; Maekawa S; Matsumoto J; Kakutani N; Furihata T; Shirakawa R; Katayama T; Nakajima T; Yamanashi K; Obata Y; Nakano I; Tsuda M; Saito A; Fukushima A; Yokota T; Nio-Kobayashi J; Yasui H; Higashikawa K; Kuge Y; Anzai T; Sabe H; Kinugawa S
    Cardiovasc Res; 2021 Feb; 117(3):805-819. PubMed ID: 32402072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central and peripheral factors mechanistically linked to exercise intolerance in heart failure with reduced ejection fraction.
    Craig JC; Colburn TD; Caldwell JT; Hirai DM; Tabuchi A; Baumfalk DR; Behnke BJ; Ade CJ; Musch TI; Poole DC
    Am J Physiol Heart Circ Physiol; 2019 Aug; 317(2):H434-H444. PubMed ID: 31225988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise training decreases NADPH oxidase activity and restores skeletal muscle mass in heart failure rats.
    Cunha TF; Bechara LR; Bacurau AV; Jannig PR; Voltarelli VA; Dourado PM; Vasconcelos AR; Scavone C; Ferreira JC; Brum PC
    J Appl Physiol (1985); 2017 Apr; 122(4):817-827. PubMed ID: 28104751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PPARdelta activation normalizes cardiac substrate metabolism and reduces right ventricular hypertrophy in congestive heart failure.
    Jucker BM; Doe CP; Schnackenberg CG; Olzinski AR; Maniscalco K; Williams C; Hu TC; Lenhard SC; Costell M; Bernard R; Sarov-Blat L; Steplewski K; Willette RN
    J Cardiovasc Pharmacol; 2007 Jul; 50(1):25-34. PubMed ID: 17666912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-Carnitine enhances exercise endurance capacity by promoting muscle oxidative metabolism in mice.
    Kim JH; Pan JH; Lee ES; Kim YJ
    Biochem Biophys Res Commun; 2015 Aug; 464(2):568-73. PubMed ID: 26164228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. γ-Oryzanol Improves Exercise Endurance and Muscle Strength by Upregulating PPARδ and ERRγ Activity in Aged Mice.
    Ahn J; Son HJ; Seo HD; Ha TY; Ahn J; Lee H; Shin SH; Jung CH; Jang YJ
    Mol Nutr Food Res; 2021 Jul; 65(14):e2000652. PubMed ID: 33932312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Phosphate Diet Induces Exercise Intolerance and Impairs Fatty Acid Metabolism in Mice.
    Peri-Okonny P; Baskin KK; Iwamoto G; Mitchell JH; Smith SA; Kim HK; Szweda LI; Bassel-Duby R; Fujikawa T; Castorena CM; Richardson J; Shelton JM; Ayers C; Berry JD; Malladi VS; Hu MC; Moe OW; Scherer PE; Vongpatanasin W
    Circulation; 2019 Mar; 139(11):1422-1434. PubMed ID: 30612451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.